Alex Grosvenor
SVP, Managing Director, International Access Strategy
Industry sage in global markets pricing and market access. Known for deep-seated understanding of international markets, strong relationships with payer experts, and significant experience in cardiovascular diseases, oncology, immunology, rare diseases, and cell and gene therapies. Key player in high-profile launches of gene therapies and other cutting-edge treatments.
Long ago in a past life
Former journalist for the Financial Times